Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Cytomegalovirus is associated with reduced telomerase activity in the Whitehall II cohort.

Dowd JB, Bosch JA, Steptoe A, Blackburn EH, Lin J, Rees-Clayton E, Aiello AE.

Exp Gerontol. 2013 Apr;48(4):385-90. doi: 10.1016/j.exger.2013.01.016. Epub 2013 Feb 9.

2.

Persistent Herpesvirus Infections and Telomere Attrition Over 3 Years in the Whitehall II Cohort.

Dowd JB, Bosch JA, Steptoe A, Jayabalasingham B, Lin J, Yolken R, Aiello AE.

J Infect Dis. 2017 Sep 1;216(5):565-572. doi: 10.1093/infdis/jix255.

PMID:
28931225
3.

Accelerated telomere shortening in leukocyte subpopulations of patients with coronary heart disease: role of cytomegalovirus seropositivity.

Spyridopoulos I, Hoffmann J, Aicher A, Brümmendorf TH, Doerr HW, Zeiher AM, Dimmeler S.

Circulation. 2009 Oct 6;120(14):1364-72. doi: 10.1161/CIRCULATIONAHA.109.854299. Epub 2009 Sep 21.

4.

High seropositivity of IgG and IgM antibodies against cytomegalovirus (CMV) among HIV-1 seropositive patients in Ilorin, Nigeria.

Fowotade A, Okonko IO, Agbede OO, Suleiman ST.

Afr Health Sci. 2015 Mar;15(1):1-9. doi: 10.4314/ahs.v15i1.1.

5.

Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia.

Kubuki Y, Suzuki M, Sasaki H, Toyama T, Yamashita K, Maeda K, Ido A, Matsuoka H, Okayama A, Nakanishi T, Tsubouchi H.

Leuk Lymphoma. 2005 Mar;46(3):393-9.

PMID:
15621829
6.

Risk factors for cytomegalovirus reactivation after liver transplantation: can pre-transplant cytomegalovirus antibody titers predict outcome?

Bruminhent J, Thongprayoon C, Dierkhising RA, Kremers WK, Theel ES, Razonable RR.

Liver Transpl. 2015 Apr;21(4):539-46. doi: 10.1002/lt.24078. Epub 2015 Mar 12.

7.

Seropositivity and higher immunoglobulin g antibody levels against cytomegalovirus are associated with mortality in the population-based European prospective investigation of Cancer-Norfolk cohort.

Gkrania-Klotsas E, Langenberg C, Sharp SJ, Luben R, Khaw KT, Wareham NJ.

Clin Infect Dis. 2013 May;56(10):1421-7. doi: 10.1093/cid/cit083. Epub 2013 Feb 26.

8.

Hostility and cellular aging in men from the Whitehall II cohort.

Brydon L, Lin J, Butcher L, Hamer M, Erusalimsky JD, Blackburn EH, Steptoe A.

Biol Psychiatry. 2012 May 1;71(9):767-73. doi: 10.1016/j.biopsych.2011.08.020. Epub 2011 Oct 5.

9.

Serology indicates cytomegalovirus infection is associated with varicella-zoster virus reactivation.

Ogunjimi B, Theeten H, Hens N, Beutels P.

J Med Virol. 2014 May;86(5):812-9. doi: 10.1002/jmv.23749. Epub 2013 Sep 13.

PMID:
24037981
10.

Multifunctional cytomegalovirus (CMV)-specific CD8(+) T cells are not restricted by telomere-related senescence in young or old adults.

Riddell NE, Griffiths SJ, Rivino L, King DC, Teo GH, Henson SM, Cantisan S, Solana R, Kemeny DM, MacAry PA, Larbi A, Akbar AN.

Immunology. 2015 Apr;144(4):549-60. doi: 10.1111/imm.12409.

11.

Immunosenescence is associated with human cytomegalovirus and shortened telomeres in type I bipolar disorder.

Rizzo LB, Do Prado CH, Grassi-Oliveira R, Wieck A, Correa BL, Teixeira AL, Bauer ME.

Bipolar Disord. 2013 Dec;15(8):832-8. doi: 10.1111/bdi.12121. Epub 2013 Sep 10.

PMID:
24021055
12.

Cross-sectional study of cytomegalovirus shedding and immunological markers among seropositive children and their mothers.

Stowell JD, Mask K, Amin M, Clark R, Levis D, Hendley W, Lanzieri TM, Dollard SC, Cannon MJ.

BMC Infect Dis. 2014 Nov 12;14:568. doi: 10.1186/s12879-014-0568-2.

13.

Seroepidemiology of cytomegalovirus infections in Croatia.

Vilibic-Cavlek T, Kolaric B, Beader N, Vrtar I, Tabain I, Mlinaric-Galinovic G.

Wien Klin Wochenschr. 2017 Feb;129(3-4):129-135. doi: 10.1007/s00508-016-1069-7. Epub 2016 Sep 6.

PMID:
27599701
14.

Serological markers as indicators for congenital cytomegalovirus infection.

Abo-Elwafa HA, Eldin SS, Sharaf AE, Abdelmonem AM.

Egypt J Immunol. 2010;17(2):1-10.

PMID:
23082482
15.

Dysregulation of Telomere Lengths and Telomerase Activity in Myelodysplastic Syndrome.

Park HS, Choi J, See CJ, Kim JA, Park SN, Im K, Kim SM, Lee DS, Hwang SM.

Ann Lab Med. 2017 May;37(3):195-203. doi: 10.3343/alm.2017.37.3.195.

16.

Impact of age, sex and CMV-infection on peripheral T cell phenotypes: results from the Berlin BASE-II Study.

Di Benedetto S, Derhovanessian E, Steinhagen-Thiessen E, Goldeck D, Müller L, Pawelec G.

Biogerontology. 2015 Oct;16(5):631-43. doi: 10.1007/s10522-015-9563-2. Epub 2015 Mar 3.

PMID:
25732234
17.

Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects.

Just-Nübling G, Korn S, Ludwig B, Stephan C, Doerr HW, Preiser W.

Infection. 2003 Oct;31(5):318-23.

PMID:
14556056
18.

National prevalence estimates for cytomegalovirus IgM and IgG avidity and association between high IgM antibody titer and low IgG avidity.

Dollard SC, Staras SA, Amin MM, Schmid DS, Cannon MJ.

Clin Vaccine Immunol. 2011 Nov;18(11):1895-9. doi: 10.1128/CVI.05228-11. Epub 2011 Sep 14.

19.

Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women.

Parrinello CM, Sinclair E, Landay AL, Lurain N, Sharrett AR, Gange SJ, Xue X, Hunt PW, Deeks SG, Hodis HN, Kaplan RC.

J Infect Dis. 2012 Jun 15;205(12):1788-96. doi: 10.1093/infdis/jis276. Epub 2012 Apr 5.

20.

Detection of cytomegalovirus infection during a vaccine clinical trial in healthy young women: seroconversion and viral shedding.

Zhang C, Buchanan H, Andrews W, Evans A, Pass RF.

J Clin Virol. 2006 Mar;35(3):338-42. Epub 2006 Jan 4.

PMID:
16388984

Supplemental Content

Support Center